Register Log-in Investor Type

Research

11 Feb 2021

QuotedData’s Round the World Webinar series – Americas day playback

On 10th February 2021, QuotedData hosted the second of four Round the World webinars. This webinar was focused on the Americas and included presentations and Q&As from 4 investment companies’ managers, covering markets across North and South America. We would like to thank all of our speakers and attendees for joining us. Click on the links […]

11 Feb 2021

QuotedData’s Economic Roundup – February 2021

Economic and Political Monthly Roundup Kindly sponsored by Allianz A collation of recent insights on markets and economies taken from the comments made by chairmen and investment managers of investment companies – have a read and make your own minds up. Please remember that nothing in this note is designed to encourage you to buy or […]

11 Feb 2021

QuotedData’s Investment Companies Roundup – February 2021

Investment Companies Monthly Roundup Kindly sponsored by Baillie Gifford and Aberdeen Standard Investments Performance January’s median total share price return from investment companies was (0.2%) (the average was 0.6%), which compares with 4.4% in December 2020. The continued allure of the private companies accessible via the growth capital sector was evident as the year began for […]

11 Feb 2021

BB Biotech AG – A leading biotech investor

A leading biotech investor BB Biotech is the oldest-established, the largest and, over the longer term, one of the best-performing of the small group of closed-end funds that specialise in the biotech sector. It offers investors a vehicle to gain exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, with a […]

11 Feb 2021

BB Biotech AG – Bold Brilliant biotech investor

Bold Brilliant biotech investor BB Biotech is the oldest-established, the largest and, over the longer term, one of the best-performing of the small group of closed-end funds that specialise in the biotech sector. It offers investors a vehicle to gain exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, with a […]

11 Feb 2021

BB Biotech AG – Bold Brilliant biotech investor

Bold Brilliant biotech investor Swiss-listed BB Biotech is the oldest-established, the largest and, over the longer term, one of the best-performing of the small group of closed-end funds that specialise in the biotech sector. It offers investors a vehicle to gain exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, with […]

05 Feb 2021

Interview with Dean Orrico from Middlefield Canadian Income

In this week’s show, James Carthew talked to Dean Orrico from Middlefield Canadian Income. Watch it again here. If you were looking for QuotedData’s roundup of the week’s news, this is now in the news section – just click here If there is a guest speaker you’d particularly like to hear from, please email us – research@quoteddata.com. […]

05 Feb 2021

QuotedData’s Round the World Webinar series – Europe day playback

On 3rd February 2021, QuotedData hosted the first of four Round the World webinars. This webinar was focused on Europe and included presentations and Q&As from 3 investment companies’ managers, covering markets across Europe. We would like to thank all of our speakers and attendees for joining us. Click on the links below to watch the […]

04 Feb 2021

QuotedData’s Round the World Webinar series – Europe day playback

On 3rd February 2021, QuotedData hosted the first of four Round the World webinars. This webinar was focused on Europe and included presentations and Q&As from 4 investment companies’ managers, covering markets across Europe. We would like to thank all of our speakers and attendees for joining us. Click on the links below to watch the […]

03 Feb 2021

Shires Income – High yield without compromising on returns

High yield without compromising on returns 2020 showed off Shires Income’s (SHRS’s) ability to deliver on its objective. By sourcing income from a wider pool than most of its peers, SHRS’s revenue account held up well relative to the wider UK market, and it managed to produce returns ahead of the average of its peers […]

03 Feb 2021

Shires Income – High yield without compromising on returns

High yield without compromising on returns 2020 showed off Shires Income’s (SHRS’s) ability to deliver on its objective. SHRS’s revenue account held up well relative to the wider UK market, which might be a reflection of it sourcing income from a wider pool than most of its peers. SHRS also managed to produce returns ahead […]

03 Feb 2021

Shires Income – High yield without compromising on returns

High yield without compromising on returns 2020 showed off Shires Income’s (SHRS’s) ability to deliver on its objective. By sourcing income from a wider pool than most of its peers, SHRS’s revenue account held up well relative to the wider UK market, and it managed to produce returns ahead of the average of its peers […]

02 Feb 2021

Strategic Equity Capital – Back to its roots

Back to its roots Since May 2020, Strategic Equity Capital (SEC) has been managed by the public equity team at Gresham House Asset Management. The head of that team, Ken Wotton, became lead-manager of the trust in September, working alongside Adam Khanbhai. The chair of SEC’s investment committee is now Tony Dalwood, SEC’s lead manager […]

02 Feb 2021

Strategic Equity Capital – Back to its roots

Back to its roots Since May 2020, Strategic Equity Capital (SEC) has been managed by the public equity team at Gresham House Asset Management. The head of that team, Ken Wotton, became lead-manager of the trust in September, working alongside Adam Khanbhai. The chair of SEC’s investment committee is now Tony Dalwood, SEC’s lead manager […]

02 Feb 2021

Strategic Equity Capital – Back to its roots

Back to its roots Since May 2020, Strategic Equity Capital (SEC) has been managed by the public equity team at Gresham House Asset Management. The head of that team, Ken Wotton, became lead-manager of the trust in September, working alongside Adam Khanbhai. The chair of SEC’s investment committee is now Tony Dalwood, SEC’s lead manager […]

29 Jan 2021

Interview with Philip Kent from GCP Infrastructure 

In this week’s show, James Carthew talked to Philip Kent from GCP Infrastructure. Watch it again here. If you were looking for QuotedData’s roundup of the week’s news, this is now in the news section – just click here If there is a guest speaker you’d particularly like to hear from, please email us – research@quoteddata.com. The […]

25 Jan 2021

AVI Global Trust – Double discount on quality-focused portfolio

Double-discount on quality-focused portfolio AVI Global Trust (AGT) offers a genuinely different investment approach to those of competing trusts. It also has a good track record of beating its performance benchmark. The manager believes that some well-timed trades and a willingness to look through the current COVID-19 disruption affecting some businesses have helped drive strong […]

25 Jan 2021

AVI Global Trust – Double discount on quality-focused portfolio

Double discount on quality-focused portfolio AVI Global Trust (AGT) offers a genuinely different investment approach to those of competing trusts. It also has a good track record of beating its performance benchmark. Some well-timed trades and a willingness to look through the current COVID-19 disruption affecting some businesses have helped drive strong performance from AGT […]

25 Jan 2021

AVI Global Trust – Double discount on quality-focused portfolio

Double discount on quality-focused portfolio AVI Global Trust (AGT) offers a genuinely different investment approach to those of competing trusts in the AIC’s global sector. It also has a good track record of beating its performance benchmark, the MSCI All Countries World ex the United States Index, with dividends reinvested and translated back into pounds. […]

22 Jan 2021

Interview with Adam Khanbhai from Strategic Equity Capital

In this week’s show, James Carthew talked to Adam Khanbhai from Strategic Equity Capital. Watch it again here If you were looking for QuotedData’s roundup of the week’s news, this is now in the news section – just click here If there is a guest speaker you’d particularly like to hear from, please email us – research@quoteddata.com. The […]

22 Jan 2021

QuotedData’s Real Estate Annual Review – 2020

Real Estate Annual Review Kindly sponsored by Aberdeen Standard Investments Riding out the COVID rollercoaster The 2020 rollercoaster saw more downs than ups and at times felt like a pandemic induced freefall. Lockdowns, tiers and plenty of U-turns meant investing in property was not for the faint hearted. Positivity returned at the end of the […]

22 Jan 2021

QuotedData’s Investment Companies Annual Review – 2020

Investment Companies Annual Review 2020 Kindly sponsored by Baillie Gifford and Aberdeen Standard Investments In this issue State of play at the end of 2020 Performance Money in and out Significant rating changes Major news and views from 2020 Outlook for 2021 Investment company notes published in 2020 Legal A year that changed the world It […]

20 Jan 2021

Pacific Horizon – Powered by technology

Pacific Horizon (PHI) generated a sizeable uplift in its NAV over the course of 2020. This appears to reflect its focus on growth, and technology and biotech stocks in particular. These performed well as the world attempted to adjust to life under the pandemic, thereby accelerating a number of structural trends. PHI provided an NAV […]

20 Jan 2021

Pacific Horizon – Powered by technology

Pacific Horizon (PHI) generated a very impressive uplift in its NAV over the course of 2020. This reflects its focus on growth, and technology and biotech stocks in particular. These performed well as we attempted to adjust to life under the pandemic, thereby accelerating a number of structural trends. PHI provided an NAV total return […]

20 Jan 2021

Pacific Horizon – Powered by technology

Pacific Horizon (PHI) generated a very impressive uplift in its NAV over the course of 2020. This reflects its focus on growth, and technology and biotechnology stocks in particular. These performed well as we attempted to adjust to life under the pandemic, thereby accelerating a number of structural trends. PHI provided an NAV total return […]

15 Jan 2021

Interview with James Robson of RM Secured Direct Lending

In this week’s show, James Carthew talked to James Robson of RM Secured Direct Lending. Watch it again here If you were looking for QuotedData’s roundup of the week’s news, this is now in the news section – just click here If there is a guest speaker you’d particularly like to hear from, please email us – […]

14 Jan 2021

QuotedData’s Real Estate Roundup – January 2021

Real Estate Roundup Kindly sponsored by Aberdeen Standard Investments Performance data December’s biggest movers in price terms are shown in the chart below. The boost of coming out of the second national lockdown in early December was short lived as Christmas was cancelled for most of the UK with COVID-19 cases spiking. It did little […]

14 Jan 2021

QuotedData’s Investment Companies Roundup – January 2021

Investment Companies Monthly Roundup Kindly sponsored by Baillie Gifford and Aberdeen Standard Investments [QD revision: We have amended an error in the original version of the roundup, published on 14 January. The table displaying December’s worst performers in total return NAV terms, using figures sourced from Morningstar, incorrectly listed Augmentum Fintech’s return as (4.1%). Augmentum’s last […]

14 Jan 2021

QuotedData’s Economic Roundup – January 2021

Economic and Political Monthly Roundup Kindly sponsored by Allianz A collation of recent insights on markets and economies taken from the comments made by chairmen and investment managers of investment companies – have a read and make your own minds up. Please remember that nothing in this note is designed to encourage you to buy or […]

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…